パーキンソン病やその他の運動障害の緩和ケア 多分野専門家グループの勧告と議定書
M Álvarez Saúco1, I Legarda Ramírez2, S Martí Martínez3
1Servicio de Neurología, Hospital General Universitario de Elche, Elche, Spain.
Neurologia
|September 6, 2025
まとめ
この研究は,緩和ケア (PC) をパーキンソン病に統合するための勧告を提供します.
科学分野:
- 神経学
- 緩和ケア
- 運動障害
背景:
- パーキンソン病 (PD) と運動障害 (MD) の緩和ケア (PC) の統合は困難です.
- PDとMDの患者にとって 限られた研修と実施がPCへのアクセスを妨げています
- 患者とその家族の生活の質を向上させることが重要な目標です.
研究 の 目的:
- PDとMDの緩和ケアのための合意による勧告を確立する.
- 緩和医療の訓練と実施の不足に対処する.
- 患者の生活の質と サポートシステムの向上
主な方法:
- スペインの神経学者の調査で 分析が必要です
- 運動障害の緩和ケアに関する包括的な文献レビュー
- PCの実施のための行動指向の勧告の策定
主要な成果:
- 神経科医の中心的な役割を強調した ニューロパリエイティブケアモデルをレビューしました
- 定義された多分野チームロール,臨床マーカー,患者選択のためのツール.
- 共有計画と包括的なアプローチに焦点を当てた緩和ケアを開始するためのプロトコルの概要
結論:
- PDとMDの管理にPCを統合することは非常に望ましい.
- 臨床実践における神経緩和ケアモデルの検証が必要である.
- PCの有効性を評価するために指標を使用すると,患者のアウトカムが改善されます.
関連する概念動画
Parkinson's Disease: Treatment
375
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
375
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Peripheral Artery Disease IV: Nursing Management
42
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
42
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Chronic Pancreatitis II: Collaborative Care
127
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
127


